Rugal hyperplastic gastritis increases the risk of gastric carcinoma, especially diffuse and p53-independent subtypes

European Journal of Gastroenterology and Hepatology

Volumn 19, Issue 7, 2007, Pages 561-566

  Oguri, Akihiko ^a   Ohmiya, Naoki ^a   Taguchi, Ayumu ^a   Itoh, Akihiro ^a   Hirooka, Yoshiki ^a   Niwa, Yasumasa ^a   Maeda, Osamu ^a   Ando, Takafumi ^a   Goto, Hidemi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Gastric cancer; p53 mutation; Pepsinogen; Rugal hyperplastic gastritis

Indexed keywords

PEPSINOGEN I; PEPSINOGEN II; PROTEIN P53;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; ATROPHIC GASTRITIS; BARIUM MEAL; CANCER INCIDENCE; CANCER RISK; CHRONIC GASTRITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SCREENING TEST; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; STOMACH RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; FEMALE; GASTRITIS, ATROPHIC; GASTROSCOPY; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; MUTATION; STOMACH NEOPLASMS;

EID: 34250203614     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32811ec056     Document Type: Article

References (38)

1. Siurala M, Sipponen P, Kekki M. Campylobacter pylori in a sample of Finnish population: relations to morphology and functions of the gastric mucosa. Gut 1988; 29:909-915.
2. Morrison S, Dahms BB, Hoffenberg E, Czinn SJ. Enlarged gastric folds in association with Campylobacter pylori gastritis. Radiology 1989; 171:819-821.
3. Stolte M, Batz C, Eidt S. Giant fold gastritis - a special form of Helicobacter pylori associated gastritis. Z Gastroenterol 1993; 31:289-293.
4. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Schlemper RJ, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345:784-789.
5. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52:6735-6740.
6. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64:31-49.
7. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Sibley RK, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325:1127-1131.
8. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perez GI, Blaser MJ. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325:1132-1136.
9. Yasunaga Y, Shinomura Y, Kanayama S, Higashimoto Y, Yabu M, Matsuzawa Y, et al. Increased production of interleukin 1 beta and hepatocyte growth factor may contribute to foveolar hyperplasia in enlarged fold gastritis. Gut 1996; 39:787-794.
10. Yasunaga Y, Bonilla-Palacios JJ, Shinomura Y, Kanayama S, Miyazaki Y, Matsuzawa Y. High prevalence of serum immunoglobulin G antibody to Helicobacter pylori and raised serum gastrin and pepsinogen levels in enlarged fold gastritis. Can J Gastroenterol 1997; 11:433-436.
11. Correa P, Shiao YH. Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res 1994; 54:1941s-1943s.
12. Tamura G, Kihana T, Nomura K, Terada M, Sugimura T, Hirohashi S. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res 1991; 51:3056-3058.
13. Rhyu MG, Park WS, Jung YJ, Choi SW, Meltzer SJ. Allelic deletions of MCC/APC and p53 are frequent late events in human gastric carcinogenesis. Gastroenterology 1994; 106:1584-1588.
14. Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S. p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int. J. Cancer 1993; 54:759-764.
15. Ohyama I, Ohmiya N, Niwa Y, Shirai K, Taguchi A, Goto H, et al. The association between tumour necrosis factor-alpha gene polymorphism and the susceptibility to rugal hyperplastic gastritis and gastric carcinoma. Eur J Gastroenterol Hepatol 2004; 16:693-700.
16. Taguchi A, Ohmiya N, Shirai K, Mabuchi N, Itoh A, Goto H, et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 2005; 14:2487-2493.
17. Ohmiya N, Matsumoto S, Yamamoto H, Baranovskaya S, Malkhosyan SR, Perucho M. Germline and somatic mutations in hMSH6 and hMSH3 in gastrointestinal cancers of the microsatellite mutator phenotype. Gene 2001; 272:301-313.
18. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982; 83:204-209.
19. Miki K, Ichinose M, Shimizu A, Huang SC, Oka H, Takahashi K, et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987; 22:133-141.
20. Stemmermann GN, Samloff IM, Nomura AM, Heilbrun LK. Serum pepsinogens I and II and stomach cancer. Clin Chim Acta 1987; 163:191-198.
21. Sipponen P, Riihela M, Hyvarinen H, Seppala K. Chronic nonatrophic ('superficial') gastritis increases the risk of gastric carcinoma. A case-control study. Scand J Gastroenterol 1994; 29:336-340.
22. Tabata H, Fuchigami T, Kobayashi H, Sakai Y, Nakanishi M, Fujishima M, et al. Helicobacter pylori and mucosal atrophy in patients with gastric cancer: a special study regarding the methods for detecting Helicobacter pylori. Dig Dis Sci 1999; 44:2027-2034.
23. Matsumoto K, Okazaki H, Nakamura T. Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts. Biochem Biophys Res Commun 1992; 188:235-43.
24. Takahashi M, Ota S, Shimada T, Hamada E, Kawabe T, Omata M, et al. Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture. J Clin Invest 1995; 95:1994-2003.
25. Han SU, Lee JH, Kim WH, Cho YK, Kim MW. Significant correlation between serum level of hepatocyte growth factor and progression of gastric carcinoma. World J Surg 1999; 23:1176-1180.
26. Calam J. Helicobacter pylori modulation of gastric acid. Yale J Biol Med 1999; 72:195-202.
27. Wang TC, Dangler CA, Chen D, Goldenring JR, Koh T, Fox JG, et al. Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer. Gastroenterology 2000; 118:36-47.
28. Nishibayashi H, Kanayama S, Kiyohara T, Yamamoto K, Miyazaki Y, Matsuzawa Y, et al. Helicobacter pylori-induced enlarged-fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma. J Gastroenterol Hepatol 2003; 18:1384-1391.
29. Shiao YH, Rugge M, Correa P, Lehmann HP, Scheer WD. p53 alteration in gastric precancerous lesions. Am J Pathol 1994; 144:511-517.
30. Ochiai A, Yamauchi Y, Hirohashi S. p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia. Int J Cancer 1996; 69:28-33.
31. Taguchi A, Ohmiya N, Itoh A, Hirooka Y, Niwa Y, Goto H, et al. Severity of atrophic gastritis related to antiparietal cell antibody and gastric carcinogenesis, including p53 mutations. J Gastroenterol Hepatol 2006; 21:545-551.
32. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Hofler H, et al. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54:3845-3852.
33. Hattori Y, Itoh H, Uchino S, Hosokawa K, Ochiai A, Terada M, et al. Immunohistochemical detection of K-sam protein in stomach cancer. Clin Cancer Res 1996; 2:1373-1381.
34. Kuniyasu H, Yasui W, Kitadai Y, Yokozaki H, Ito H, Tahara E. Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun 1992; 189:227-232.
35. Tahara E. Molecular biology of gastric cancer. World J Surg 1995; 19:484-490.
36. Horii A, Nakatsuru S, Miyoshi Y, Ichii S, Nagase H, Nakamura Y, et al. The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res 1992; 52:3231-3233.
37. Yasunaga Y, Shinomura Y, Kanayama S, Yabu M, Nakanishi T, Matsuzawa Y, et al. Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis. Gut 1994; 35:1571-1574.
38. Murayama Y, Miyagawa J, Shinomura Y, Kanayama S, Yasunaga Y, Matsuzawa Y, et al. Morphological and functional restoration of parietal cells in Helicobacter pylori associated enlarged fold gastritis after eradication. Gut 1999; 45:653-661.